Dr. reddy's q3 & 9m fy21 financial results

Hyderabad, india--(business wire)--dr. reddy's laboratories ltd. (bse: 500124 | nse: drreddy | nyse: rdy | nseifsc: drreddy) today announced its consolidated financial results for the quarter and the nine months ended december 31, 2020. the information mentioned in this release is on the basis of consolidated financial statements under international financial reporting standards (ifrs). q3 performance summary 9m performance summary     rs. 4,930 cr rs. 14,244 cr revenue revenue [up: 12% yoy; 1%
RDY Ratings Summary
RDY Quant Ranking